Timothy Walsh

Professor Timothy Walsh serves as Chair of Critical Care at the University of Edinburgh's Usher Institute within the College of Medicine and Veterinary Medicine. He concurrently holds the position of Director of Innovation for NHS Lothian and Health Innovation South East Scotland, bridging academic research with clinical implementation. His dual roles position him at the forefront of critical care research and healthcare innovation in the UK.

Walsh's research spans critical and perioperative care, with a programmatic approach building complex multi-center trials. His work integrates epidemiology, systematic reviews, cohort studies, and stakeholder engagement to develop pragmatic trials. Recent focus includes AI algorithm validation, sedation protocols, transfusion medicine, and sepsis management. His fingerprint reveals deep expertise in Intensive Care Medicine (100%), Intensive Care Unit operations (74%), and Critical Illness (70%), with notable contributions to sedation research (35%) and sepsis (26%).

His 221 research outputs include high-impact publications in NEJM, JAMA, and The Lancet. Current projects like the SHORTER antibiotic trial and aerosolized virus quantification study demonstrate ongoing leadership in trial methodology. As Director of Innovation for NHS Lothian (2018-2024), he established data-driven innovation frameworks connecting academic and industry partners to address NHS challenges.

Walsh has secured £9 million as Chief Investigator and £34 million as co-applicant from NIHR, MRC, Wellcome, and industry sources. His leadership extends to founding the NIHR critical care specialty group (2007-15) and UK critical care research group (2007-16), which remain foundational to UK critical care research infrastructure.

• Trustee at Chest Heart & Stroke Scotland (2021-present)
• Director of Research & Development for NHS Lothian (2017-2021)
• Chair of 19 trial steering/data safety monitoring committees
• Leadership in 13 ECTU trials, 9 UK trials, and multiple international studies